NCT05532319 2025-12-30
FRONT-1
Guangxi Medical University
Phase 2 Completed
Clinical Trials
4 trialsNCT05185739 2024-12-06
PRIMER-1
University College, London
Phase 2 Recruiting
NCT06563934 2024-08-21
Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)
Shenzhen Third People's Hospital
Phase 2 Not yet recruiting
NCT05171335 2022-09-21
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
The Methodist Hospital Research Institute
Phase 2 Enrolling by invitation